Conditioning with Busulfan Plus Melphalan (Bu-Mel) Results in More Prolonged Progression-Free Survival (PFS) Versus Melphalan (Mel) Alone before Autologous Stem Cell Transplantation (auto-HCT) in Patients with High-Risk Multiple Myeloma (MM): Long-Term Results of a Randomized, Phase 3 Trial | Zendy

Qaiser Bashir | Zendy; Peter F. Thall | Zendy; Denái R. Milton | Zendy; Jitesh D. Kawedia | Zendy; Partow Kebriaei | Zendy; Krina K. Patel | Zendy; Börje S. Andersson | Zendy; Yago Nieto | Zendy; Ben C. Valdez | Zendy; Simrit Parmar | Zendy; Gabriela Rondón | Zendy; Ruby Delgado | Zendy; Chitra Hosing | Zendy; Uday Popat | Zendy; Betül Oran | Zendy; Stefan O. Ciurea | Zendy; Pei Lin | Zendy; Donna Weber | Zendy; Sheeba K. Thomas | Zendy; Hans C. Lee | Zendy; Elisabet E. Manasanch | Zendy; Robert Z. Orlowski | Zendy; Elizabeth J. Shpall | Zendy; Loretta A. Williams | Zendy; Richard E. Champlin | Zendy; Muzaffar H. Qazilbash | Zendy

Open Access

Conditioning with Busulfan Plus Melphalan (Bu-Mel) Results in More Prolonged Progression-Free Survival (PFS) Versus Melphalan (Mel) Alone before Autologous Stem Cell Transplantation (auto-HCT) in Patients with High-Risk Multiple Myeloma (MM): Long-Term Results of a Randomized, Phase 3 Trial

Author(s) -

Qaiser Bashir,

Peter F. Thall,

Denái R. Milton,

Jitesh D. Kawedia,

Partow Kebriaei,

Krina K. Patel,

Börje S. Andersson,

Yago Nieto,

Ben C. Valdez,

Simrit Parmar,

Gabriela Rondón,

Ruby Delgado,

Chitra Hosing,

Uday Popat,

Betül Oran,

Stefan O. Ciurea,

Pei Lin,

Donna Weber,

Sheeba K. Thomas,

Hans C. Lee,

Elisabet E. Manasanch,

Robert Z. Orlowski,

Elizabeth J. Shpall,

Loretta A. Williams,

Richard E. Champlin,

Muzaffar H. Qazilbash

Publication year - 2020

Publication title -

biology of blood and marrow transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.301

H-Index - 120

eISSN - 1523-6536

pISSN - 1083-8791

DOI - 10.1016/j.bbmt.2019.12.488

Subject(s) - medicine , melphalan , busulfan , multiple myeloma , transplantation , surgery , progression free survival , autologous stem cell transplantation , oncology , gastroenterology , urology , chemotherapy , hematopoietic stem cell transplantation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research